期刊文献+

Treatment of uncomplicated reflux disease 被引量:3

Treatment of uncomplicated reflux disease
下载PDF
导出
摘要 Uncomplicated reflux disease comprises the non-erosive reflux disease (NERD) and erosive reflux disease (ERD).The objectives of treatment are the adequate control of symptoms with restoration of quality of life, healing of lesions and prevention of relapse. Treatment of NERD consists in the administration of proton pump inhibitors (PPI) for 2-4 wk, although patients with NERD show an overall poorer response to PPI treatment than patients with ERD owing to the fact that patients with NERD do not form a pathophysiologically homogenous group. For long-term management on-demand treatment with a PPI is probably the best option. In patients with ERD, therapy with a standard dose PPI for 4-8 wk is always recommended.Long-term treatment of ERD is applied either intermittently or as continuous maintenance treatment with an attempt to reduce the daily dosage of the PPI (step-down principle).In selected patients requiring long-term PPI treatment,antireflux surgery is an alternative option. In patients with troublesome reflux symptoms and without alarming features empirical PPI therapy is another option for initial management. Therapy should be withdrawn after initial success. In the case of relapse, the long-term care depends on a careful risk assessment and the response to PPI therapy. Uncomplicated reflux disease comprises the non-erosive reflux disease (NERD) and erosive reflux disease (ERD). The objectives of treatment are the adequate control of symptoms with restoration of quality of life, healing of lesions and prevention of relapse. Treatment of NERD consists in the administration of proton pump inhibitors (PPI) for 2-4 wk, although patients with NERD show an overall poorer response to PPI treatment than patients with ERD owing to the fact that patients with NERD do not form a pathophysiologically homogenous group. For long-term management on-demand treatment with a PPI is probably the best option. In patients with ERD, therapy with a standard dose PPI for 4-8 wk is always recommended. Long-term treatment of ERD is applied either intermittently or as continuous maintenance treatment with an attempt to reduce the daily dosage of the PPI (step-down principle). In selected patients requiring long-term PPI treatment, antireflux surgery is an alternative option. In patients with troublesome reflux symptoms and without alarming features empirical PPI therapy is another option for initial management. Therapy should be withdrawn after initial success. In the case of relapse, the long-term caredepends on a careful risk assessment and the response to PPI therapy.
出处 《World Journal of Gastroenterology》 SCIE CAS CSCD 2005年第28期4291-4299,共9页 世界胃肠病学杂志(英文版)
关键词 逆流性疾病 消化系疾病 治疗方法 质子泵抑制剂 Erosive reflux disease Non-erosive reflux disease Proton pump inhibitor Uninvestigated reflux disease
  • 相关文献

参考文献91

  • 1Locke GR, Talley J, Fett SL, Zinsmeister AR, Melton LJ. Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Olmsted County, Minnesota. Gastroenterology 1997; 112:1448-1456.
  • 2Quigley EM. Non-erosive reflux disease (NERD); part of the spectrum of gastro-oesophageal reflux, a component of functional dyspepsia, or both? Eur J Gastroenterol Hepatol 2001; 13(Suppl 1): S13-18.
  • 3Fass R, Ofman JJ. Gastroesophageal reflux disease - should we adopt a new conceptual framework? Am J Gastroenterol 2002; 97; 1901-1907.
  • 4Dent J, Brun J, Fendrick AM, Fennerty MB, Janssens J, Kahrilas PJ, Lauritsen K, Reynolds JC, Shaw N, Talley NJ. An evidence-based appraisal Of reflux disease management - the Genval Workshop Report. Gut 1999; 44(Suppl 2): S1-S16.
  • 5Dent J. Management of reflux disease. Gut 2002; 50(Suppl 4);iv67-71.
  • 6Dent J, Armstrong D, Delaney B, Moayyedi P, Talley NJ,Vakil N. Symptom evaluation in reflux disease: workshop background, processes, terminology, recommendations, and discussion outputs. Gut 2004; 53(Suppl 4): iv1-24.
  • 7Klauser AG, Schindlbeck NE, Muiller-Lissner SA. Symptoms in gastro-oesophageal reflux disease. Lancet 1990; 335:205-208.
  • 8Martinez SD, Malagon IB, Garewal HS, Cui H, Fass R. Nonerosive reflux disease (NERD) - acid reflux and symptom loatterns. Aliment Pharmacol Ther 2003; 17;537-545.
  • 9kulig M, Nocon M, Vieth M, Leodolter A, Jaspersen D, Labenz J, Meyer-Sabellek W, Stolte M, Lind T, Malfertheiner P, Willich SN. Risk factors of gastroesophageal reflux disease: methodology and first epidemiological results of the ProGERD study.J Clin Epidemiol 2004; 57; 580-589.
  • 10Junghard O, Carlsson R, Lind T. Sufficient control of heartbum in endoscopy-negative gastro-oesophageal reflux disease trials. Scand J Gastroenterol 2003; 38:1197-1199.

同被引文献22

引证文献3

二级引证文献780

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部